Annual D&A
$6.29 B
+$1.23 B+24.21%
31 December 2023
Summary:
Pfizer annual depreciation & amortization is currently $6.29 billion, with the most recent change of +$1.23 billion (+24.21%) on 31 December 2023. During the last 3 years, it has risen by +$1.51 billion (+31.67%). PFE annual D&A is now -30.31% below its all-time high of $9.03 billion, reached on 31 December 2011.PFE Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$1.75 B
+$24.00 M+1.39%
30 September 2024
Summary:
Pfizer quarterly depreciation & amortization is currently $1.75 billion, with the most recent change of +$24.00 million (+1.39%) on 30 September 2024. Over the past year, it has increased by +$195.00 million (+12.50%). PFE quarterly D&A is now -28.60% below its all-time high of $2.46 billion, reached on 31 December 2011.PFE Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$6.89 B
+$195.00 M+2.91%
30 September 2024
Summary:
Pfizer TTM depreciation & amortization is currently $6.89 billion, with the most recent change of +$195.00 million (+2.91%) on 30 September 2024. Over the past year, it has increased by +$753.00 million (+12.27%). PFE TTM D&A is now -24.62% below its all-time high of $9.14 billion, reached on 01 March 2012.PFE TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PFE Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +24.2% | +12.5% | +12.3% |
| 3 y3 years | +31.7% | +30.9% | +36.2% |
| 5 y5 years | +2.3% | +13.0% | +14.2% |
PFE Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +31.7% | at high | +49.4% | at high | +41.2% |
| 5 y | 5 years | at high | +31.7% | at high | +55.5% | at high | +46.6% |
| alltime | all time | -30.3% | +2937.2% | -28.6% | +3410.0% | -24.6% | >+9999.0% |
Pfizer Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.75 B(+1.4%) | $6.89 B(+2.9%) |
| June 2024 | - | $1.73 B(-0.3%) | $6.70 B(+2.4%) |
| Mar 2024 | - | $1.74 B(+4.0%) | $6.54 B(+4.0%) |
| Dec 2023 | $6.29 B(+24.2%) | $1.67 B(+7.1%) | $6.29 B(+2.5%) |
| Sept 2023 | - | $1.56 B(-0.8%) | $6.14 B(+6.5%) |
| June 2023 | - | $1.57 B(+5.8%) | $5.76 B(+7.4%) |
| Mar 2023 | - | $1.49 B(-2.1%) | $5.36 B(+5.9%) |
| Dec 2022 | $5.06 B(-2.4%) | $1.52 B(+28.4%) | $5.06 B(+3.8%) |
| Sept 2022 | - | $1.18 B(+0.7%) | $4.88 B(-3.1%) |
| June 2022 | - | $1.18 B(-1.0%) | $5.04 B(-2.6%) |
| Mar 2022 | - | $1.19 B(-11.1%) | $5.17 B(-0.4%) |
| Dec 2021 | $5.19 B(+8.7%) | $1.33 B(-0.4%) | $5.19 B(+2.6%) |
| Sept 2021 | - | $1.34 B(+2.5%) | $5.06 B(+2.7%) |
| June 2021 | - | $1.31 B(+8.4%) | $4.93 B(+2.3%) |
| Mar 2021 | - | $1.21 B(+0.2%) | $4.82 B(+0.9%) |
| Dec 2020 | $4.78 B(-17.0%) | $1.20 B(-0.3%) | $4.78 B(+1.6%) |
| Sept 2020 | - | $1.21 B(+0.8%) | $4.70 B(-6.8%) |
| June 2020 | - | $1.20 B(+2.8%) | $5.05 B(-6.1%) |
| Mar 2020 | - | $1.17 B(+3.3%) | $5.38 B(-6.6%) |
| Dec 2019 | $5.75 B(-6.4%) | $1.13 B(-27.3%) | $5.75 B(-4.6%) |
| Sept 2019 | - | $1.55 B(+1.6%) | $6.03 B(-1.0%) |
| June 2019 | - | $1.53 B(-1.1%) | $6.09 B(-0.6%) |
| Mar 2019 | - | $1.54 B(+9.8%) | $6.13 B(-0.4%) |
| Dec 2018 | $6.15 B(-1.9%) | $1.41 B(-12.8%) | $6.15 B(-2.6%) |
| Sept 2018 | - | $1.61 B(+3.3%) | $6.32 B(+0.8%) |
| June 2018 | - | $1.56 B(-0.3%) | $6.27 B(-0.2%) |
| Mar 2018 | - | $1.57 B(-0.4%) | $6.28 B(+0.2%) |
| Dec 2017 | $6.27 B(+8.9%) | $1.57 B(+0.5%) | $6.27 B(+0.4%) |
| Sept 2017 | - | $1.57 B(-0.5%) | $6.24 B(+2.8%) |
| June 2017 | - | $1.57 B(+1.2%) | $6.07 B(+3.2%) |
| Mar 2017 | - | $1.55 B(+0.4%) | $5.89 B(+2.3%) |
| Dec 2016 | $5.76 B(+11.6%) | $1.55 B(+11.0%) | $5.76 B(+2.2%) |
| Sept 2016 | - | $1.40 B(+0.6%) | $5.63 B(+2.3%) |
| June 2016 | - | $1.39 B(-2.7%) | $5.51 B(+3.5%) |
| Mar 2016 | - | $1.43 B(+0.1%) | $5.32 B(+3.2%) |
| Dec 2015 | $5.16 B(-6.9%) | $1.42 B(+11.9%) | $5.16 B(+1.8%) |
| Sept 2015 | - | $1.27 B(+5.9%) | $5.06 B(-1.1%) |
| June 2015 | - | $1.20 B(-4.7%) | $5.12 B(-4.2%) |
| Mar 2015 | - | $1.26 B(-5.3%) | $5.34 B(-3.5%) |
| Dec 2014 | $5.54 B(-13.6%) | $1.33 B(+0.4%) | $5.54 B(-2.8%) |
| Sept 2014 | - | $1.33 B(-6.9%) | $5.70 B(-3.3%) |
| June 2014 | - | $1.42 B(-2.2%) | $5.89 B(-3.3%) |
| Mar 2014 | - | $1.46 B(-2.2%) | $6.09 B(-5.0%) |
| Dec 2013 | $6.41 B(-16.3%) | $1.49 B(-2.1%) | $6.41 B(-8.8%) |
| Sept 2013 | - | $1.52 B(-6.5%) | $7.03 B(-1.9%) |
| June 2013 | - | $1.63 B(-8.3%) | $7.16 B(-0.6%) |
| Mar 2013 | - | $1.77 B(-15.8%) | $7.21 B(-5.8%) |
| Dec 2012 | $7.66 B(-15.2%) | $2.11 B(+27.2%) | $7.66 B(-4.4%) |
| Sept 2012 | - | $1.66 B(-0.9%) | $8.01 B(-6.5%) |
| June 2012 | - | $1.67 B(-24.8%) | $8.56 B(-6.3%) |
| Mar 2012 | - | $2.22 B(-9.6%) | $9.14 B(+1.3%) |
| Dec 2011 | $9.03 B(+7.5%) | $2.46 B(+11.0%) | $9.03 B(+6.5%) |
| Sept 2011 | - | $2.21 B(-1.5%) | $8.47 B(-0.2%) |
| June 2011 | - | $2.25 B(+6.9%) | $8.49 B(+0.4%) |
| Mar 2011 | - | $2.10 B(+10.4%) | $8.45 B(+0.6%) |
| Dec 2010 | $8.40 B(+76.6%) | $1.91 B(-14.5%) | $8.40 B(+1.6%) |
| Sept 2010 | - | $2.23 B(+0.7%) | $8.27 B(+18.0%) |
| June 2010 | - | $2.21 B(+7.9%) | $7.01 B(+20.8%) |
| Mar 2010 | - | $2.05 B(+15.6%) | $5.80 B(+21.9%) |
| Dec 2009 | $4.76 B(-6.5%) | $1.77 B(+83.1%) | $4.76 B(+14.3%) |
| Sept 2009 | - | $969.00 M(-3.7%) | $4.16 B(-5.2%) |
| June 2009 | - | $1.01 B(-0.2%) | $4.39 B(-4.8%) |
| Mar 2009 | - | $1.01 B(-14.4%) | $4.61 B(-9.4%) |
| Dec 2008 | $5.09 B(-2.1%) | $1.18 B(-1.5%) | $5.09 B(+1.2%) |
| Sept 2008 | - | $1.20 B(-2.7%) | $5.03 B(-3.4%) |
| June 2008 | - | $1.23 B(-17.4%) | $5.20 B(-3.9%) |
| Mar 2008 | - | $1.49 B(+33.2%) | $5.42 B(+4.2%) |
| Dec 2007 | $5.20 B | $1.12 B(-18.7%) | $5.20 B(-2.8%) |
| Sept 2007 | - | $1.37 B(-4.8%) | $5.35 B(+0.8%) |
| June 2007 | - | $1.44 B(+13.4%) | $5.31 B(+1.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2007 | - | $1.27 B(+0.3%) | $5.21 B(-1.5%) |
| Dec 2006 | $5.29 B(-5.1%) | $1.27 B(-4.9%) | $5.29 B(-3.0%) |
| Sept 2006 | - | $1.33 B(-0.8%) | $5.46 B(-0.6%) |
| June 2006 | - | $1.34 B(-0.6%) | $5.49 B(-1.2%) |
| Mar 2006 | - | $1.35 B(-5.7%) | $5.56 B(-0.3%) |
| Dec 2005 | $5.58 B(+9.5%) | $1.43 B(+4.8%) | $5.58 B(+2.2%) |
| Sept 2005 | - | $1.37 B(-3.0%) | $5.45 B(+1.9%) |
| June 2005 | - | $1.41 B(+3.2%) | $5.35 B(+3.0%) |
| Mar 2005 | - | $1.37 B(+4.2%) | $5.20 B(+2.1%) |
| Dec 2004 | $5.09 B(+26.5%) | $1.31 B(+3.6%) | $5.09 B(-7.5%) |
| Sept 2004 | - | $1.26 B(+0.7%) | $5.50 B(+3.1%) |
| June 2004 | - | $1.26 B(-0.4%) | $5.34 B(+6.4%) |
| Mar 2004 | - | $1.26 B(-26.8%) | $5.02 B(+24.6%) |
| Dec 2003 | $4.03 B(+288.5%) | $1.72 B(+56.8%) | $4.03 B(+54.6%) |
| Sept 2003 | - | $1.10 B(+17.3%) | $2.60 B(+48.3%) |
| June 2003 | - | $936.00 M(+248.0%) | $1.75 B(+65.7%) |
| Mar 2003 | - | $269.00 M(-10.3%) | $1.06 B(+2.2%) |
| Dec 2002 | $1.04 B(+6.6%) | $300.00 M(+20.0%) | $1.04 B(+10.7%) |
| Sept 2002 | - | $250.00 M(+4.2%) | $936.00 M(0.0%) |
| June 2002 | - | $240.00 M(-2.4%) | $936.00 M(-2.9%) |
| Mar 2002 | - | $246.00 M(+23.0%) | $964.00 M(-0.8%) |
| Dec 2001 | $972.00 M(+0.4%) | $200.00 M(-20.0%) | $972.00 M(-5.9%) |
| Sept 2001 | - | $250.00 M(-6.7%) | $1.03 B(+1.6%) |
| June 2001 | - | $268.00 M(+5.5%) | $1.02 B(+4.0%) |
| Mar 2001 | - | $254.00 M(-2.7%) | $978.00 M(+1.0%) |
| Dec 2000 | $968.00 M(+7.0%) | $261.00 M(+11.5%) | $968.00 M(-0.5%) |
| Sept 2000 | - | $234.00 M(+2.2%) | $973.00 M(+0.8%) |
| June 2000 | - | $229.00 M(-6.1%) | $965.00 M(-5.5%) |
| Mar 2000 | - | $244.00 M(-8.3%) | $1.02 B(+12.8%) |
| Dec 1999 | $905.00 M(+13.6%) | $266.00 M(+17.7%) | $905.00 M(-8.8%) |
| Sept 1999 | - | $226.00 M(-20.7%) | $992.00 M(+1.7%) |
| June 1999 | - | $285.00 M(+122.7%) | $975.00 M(+20.8%) |
| Mar 1999 | - | $128.00 M(-63.7%) | $807.00 M(+1.3%) |
| Dec 1998 | $797.00 M(+86.2%) | $353.00 M(+68.9%) | $797.00 M(+44.1%) |
| Sept 1998 | - | $209.00 M(+78.6%) | $553.00 M(+32.0%) |
| June 1998 | - | $117.00 M(-0.8%) | $419.00 M(-3.0%) |
| Mar 1998 | - | $118.00 M(+8.3%) | $432.00 M(+0.9%) |
| Dec 1997 | $428.00 M(+19.2%) | $109.00 M(+45.3%) | $428.00 M(+16.0%) |
| Sept 1997 | - | $75.00 M(-42.3%) | $369.00 M(-6.8%) |
| June 1997 | - | $130.00 M(+14.0%) | $396.00 M(+6.5%) |
| Mar 1997 | - | $114.00 M(+128.0%) | $372.00 M(+3.6%) |
| Dec 1996 | $359.00 M(-4.0%) | $50.00 M(-51.0%) | $359.00 M(-13.9%) |
| Sept 1996 | - | $102.00 M(-3.8%) | $416.80 M(+4.2%) |
| June 1996 | - | $106.00 M(+5.0%) | $400.10 M(+11.3%) |
| Mar 1996 | - | $101.00 M(-6.3%) | $359.40 M(-3.9%) |
| Dec 1995 | $374.00 M(+28.1%) | $107.80 M(+26.4%) | $374.00 M(+8.5%) |
| Sept 1995 | - | $85.30 M(+30.6%) | $344.60 M(+3.4%) |
| June 1995 | - | $65.30 M(-43.5%) | $333.40 M(-0.9%) |
| Mar 1995 | - | $115.60 M(+47.4%) | $336.50 M(+15.2%) |
| Dec 1994 | $292.00 M(+13.1%) | $78.40 M(+5.8%) | $292.00 M(+4.1%) |
| Sept 1994 | - | $74.10 M(+8.3%) | $280.60 M(+3.0%) |
| June 1994 | - | $68.40 M(-3.8%) | $272.50 M(+2.0%) |
| Mar 1994 | - | $71.10 M(+6.1%) | $267.20 M(+3.5%) |
| Dec 1993 | $258.20 M(-2.2%) | $67.00 M(+1.5%) | $258.20 M(+0.9%) |
| Sept 1993 | - | $66.00 M(+4.6%) | $256.00 M(-1.1%) |
| June 1993 | - | $63.10 M(+1.6%) | $258.90 M(-0.5%) |
| Mar 1993 | - | $62.10 M(-4.2%) | $260.30 M(-1.4%) |
| Dec 1992 | $263.90 M(+8.1%) | $64.80 M(-6.0%) | $263.90 M(+2.0%) |
| Sept 1992 | - | $68.90 M(+6.8%) | $258.80 M(+3.1%) |
| June 1992 | - | $64.50 M(-1.8%) | $250.90 M(+1.0%) |
| Mar 1992 | - | $65.70 M(+10.1%) | $248.50 M(+1.8%) |
| Dec 1991 | $244.10 M(+8.6%) | $59.70 M(-2.1%) | $244.10 M(+1.4%) |
| Sept 1991 | - | $61.00 M(-1.8%) | $240.70 M(+1.8%) |
| June 1991 | - | $62.10 M(+1.3%) | $236.40 M(+3.2%) |
| Mar 1991 | - | $61.30 M(+8.9%) | $229.00 M(+1.9%) |
| Dec 1990 | $224.80 M(+8.5%) | $56.30 M(-0.7%) | $224.80 M(+33.4%) |
| Sept 1990 | - | $56.70 M(+3.7%) | $168.50 M(+50.7%) |
| June 1990 | - | $54.70 M(-4.2%) | $111.80 M(+95.8%) |
| Mar 1990 | - | $57.10 M | $57.10 M |
| Dec 1989 | $207.10 M | - | - |
FAQ
- What is Pfizer annual depreciation & amortization?
- What is the all time high annual D&A for Pfizer?
- What is Pfizer annual D&A year-on-year change?
- What is Pfizer quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Pfizer?
- What is Pfizer quarterly D&A year-on-year change?
- What is Pfizer TTM depreciation & amortization?
- What is the all time high TTM D&A for Pfizer?
- What is Pfizer TTM D&A year-on-year change?
What is Pfizer annual depreciation & amortization?
The current annual D&A of PFE is $6.29 B
What is the all time high annual D&A for Pfizer?
Pfizer all-time high annual depreciation & amortization is $9.03 B
What is Pfizer annual D&A year-on-year change?
Over the past year, PFE annual depreciation & amortization has changed by +$1.23 B (+24.21%)
What is Pfizer quarterly depreciation & amortization?
The current quarterly D&A of PFE is $1.75 B
What is the all time high quarterly D&A for Pfizer?
Pfizer all-time high quarterly depreciation & amortization is $2.46 B
What is Pfizer quarterly D&A year-on-year change?
Over the past year, PFE quarterly depreciation & amortization has changed by +$195.00 M (+12.50%)
What is Pfizer TTM depreciation & amortization?
The current TTM D&A of PFE is $6.89 B
What is the all time high TTM D&A for Pfizer?
Pfizer all-time high TTM depreciation & amortization is $9.14 B
What is Pfizer TTM D&A year-on-year change?
Over the past year, PFE TTM depreciation & amortization has changed by +$753.00 M (+12.27%)